Shree Amman Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 24 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 46.22 Cr
About Shree Amman Pharma
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51397TG2000PTC168011
-
Company No.
044353
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Mar 2000
-
Date of AGM
16 Aug 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Shree Amman Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Somu Baskaran
|
Managing Director | 09-Mar-2000 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Palepu Gopal
|
Nominee Director | 03-May-2019 | Current |
|
Arvind Venkat
|
Nominee Director | 03-May-2019 | Current |
|
Balasubramaniam Jayakumar
|
Whole-Time Director | 09-Mar-2000 | Current |
Financial Performance of Shree Amman Pharma.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Amman Pharma?
Unlock access to Shree Amman Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Indian Hospitex Private LimitedPalepu Gopal is a mutual person
-
Keimed Private LimitedArvind Venkat is a mutual person
-
Neelkanth Drugs Private LimitedArvind Venkat is a mutual person
-
Sri Balajhi Logistics Pharma LlpPalepu Gopal and Somu Baskaran are mutual person
-
Pleasant Exports India Llp
Palepu Gopal is a mutual person
-
Pleasant Foods Private Limited
Palepu Gopal is a mutual person
Charges (Loans)
₹0
₹46.22 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 28.42 Cr
- Dbs Bank Ltd : 10.00 Cr
- Standard Chartered Bank : 6.50 Cr
- Standard Charterf Bank : 1.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Feb 2023 | Hdfc Bank Limited | ₹6.20 M | Satisfied |
| 22 May 2020 | Hdfc Bank Limited | ₹8.00 M | Satisfied |
| 27 Mar 2019 | Hdfc Bank Limited | ₹27.00 Cr | Satisfied |
| 10 Apr 2014 | Dbs Bank Ltd | ₹10.00 Cr | Satisfied |
| 23 Apr 2007 | Standard Chartered Bank | ₹6.50 Cr | Satisfied |
How Many Employees Work at Shree Amman Pharma?
Unlock and access historical data on people associated with Shree Amman Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Amman Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Amman Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
